ロード中...
Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury
BACKGROUND: A sodium-glucose co-transporter 2 (SGLT-2) inhibitor had favorable impact on the attenuation of hyperglycemia together with the severity of heart failure. However, the effects of acute dapagliflozin administration at the time of cardiac ischemia/reperfusion (I/R) injury are not establish...
保存先:
| 出版年: | Cardiovasc Diabetol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7296726/ https://ncbi.nlm.nih.gov/pubmed/32539724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-01066-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|